Abstract A formula to calculate recurrence risk for germline mosaicism published by Hartl in 1971 has been updated to include marker information. For practical genetic counselling new, more elaborate tables are given. (J Med Genet 1995;32:102-104) In 1974 Murphy et all concluded "From the clinical standpoint the main implication is that it provides reassurance that, in any realistic size of family, ignoring the effect of gonadal mosaicism will have little effect on the estimate of the risk for the next child". This paper has been referred to many times in papers about mosaicism. A paper by Hartl,' entitled "Recurrence risk for germinal mosaics", gives formulae to calculate recurrence risks, correcting for the number of affected and unaffected sibs. This paper will discuss the impact of modem molecular genetic techniques on the recurrence risk for gonadal mosaicism.
The theory In all humans some degree of mosaicism is the norm for the more common genetic disorders, since the mutation rate multiplied by the number of mitoses necessary to form the 5-7 million3 or 8 million oocytes4 in females and the many more spermatozoa in males is much higher than one. In mosaics distinction has to be made between somatic and germline mosaics. In somatic mosaics the germ stem cell is mutated. This mutation happens in one of the 46 chromosomes (2n) in a mitosis between fertilisation and the mitoses leading to the germ stem cell. In somatic mosaics all gonadal cells before meiosis will have the same mutation on one chromosome, and because of the meiosis in which a 2n chromosome cell is split into two cells with n chromosomes, there is a 50% recurrence risk. In germline mosaics a fraction of the gonadal cells will have a mutation. This is dependent on the gonadal generation in which the mutation occurred, since all descendent cells of the mutated cell are carriers of the mutation. For a more detailed description of this model see Murphy et al. 1 The recurrence risk is dependent on the gonadal generation in which the mutation occurred to a maximum of 50% (first gonadal generation mutation).
The recurrence risk owing to germline mosaicism can be explained through the development of all 2n oocytes from one healthy wild type cell. In 2', n is the number of cell generations to get from one healthy cell to the total amount of oocytes. Hartl' showed that more complex models than this simple model do not change recurrence risks as long as the number of gonadal generations is high enough. If we assume that during gametogenesis the probability of mutation in each gonadal generation, conditional on the occurrence of a mosaic genotype, is the same for all cell generations, the recurrence risk owing to germline mosaicism, only taking into account the information that one parent is a mosaic, can be calculated from the number of cell generations n to be Recurrence risk=Z _l*(2) -i1_. Table 2 Recurrence risk for gonadal mosaics with two affected children (a = 2) and a variable number of untyped unaffected children (b) and typed unaffected children with the at risk chromosome (c) Affected: 100% chance of having the risk chromosome, R% of the sibs;
Unaffected: (50-R)% chance of having the risk chromosome, 50% of having the not risk chromosome. Total (100-R)% of the sibs. Typed sibs: first of all to be used to determine if the grandmaternal or the grandpaternal chromosome is the mosaic chromosome.
Affected: has the at risk chromosome, informative to increase recurrence risk, R% of the sibs.
Unaffected: having the at risk chromosome, informative to decrease a priori risk, (50-R)% of the sibs; not having the at risk chromosome, not informative, except for determination on which chromosome the mutation occurred (grandpaternal or grandmaternal), 50% of the sibs.
From all the classes mentioned above, the three informative classes have to be included in a risk calculation: the affected (A), the untyped unaffected (B), and the typed unaffected with the at risk chromosome (C). The unaffected sibs who are typed and have the non-mosaic chromosome are not informative, because they do not provide information about the frequency of the mosaic chromosome and therefore of the recurrence risk R.
Extending the recurrence risk formula as given by Hartl2 with the third class of typed unaffected children with the at risk chromosome leads to the straightforward Bayesian formula, where P(A/F) is the probability that the next child born to a mosaic parent is affected, given the distribution F of the number of affected children (a), untyped unaffected children (b), and typed unaffected children with the risk chromosome (c). Details of derivation of the formula are shown in the appendix.
Results Since the formula is quite complex, recurrence risks are calculated and shown in tables 1 to 4 for the situations which appear most often in practical genetic counselling. The recurrence risks are calculated given at least one affected child. Wijsman3 and Edwards4 estimated that the number of gonadal generations n must be approximately 23 in females and approximately 30 in males. Recurrence risks are almost constant if n is greater or equal to 20 and because we do not want to underestimate the recurrence risk, n is set to 20. The risks in the last column of table 1 from Hartl2 can then be found in the tables. The risks in the tables are the recurrence risks for the next child given the pedigree with at least one affected child and no chromosomal information on the "newborn". Prenatal information on the inherited chromosome of the "newborn" reduces the risk to 0 if the not at risk chromosome is encountered or doubles the risk as stated in the tables otherwise.
Discussion
One of the major problems in risk calculation for germline mosaics is the impact on the recurrence risk in comparison to the impact of somatic mosaics and, in X linked recessive cases, the carrier probability of the mother. In Duchenne muscular dystrophy (X linked) onethird of the cases are thought to be the result ofa new mutation.89 Ifparents are non-carriers, as can be seen from their phenotype in dominant cases, the mutation must be either somatic or germinal. Although it is unclear how to divide probabilities over somatic and germline mosaics, the impact of somatic mosaics is higher because in this case 50% of the children are affected against approximately 5% in germline mosaics. However, one of the advantages of modern genetic technology is the ability to determine which chromosome is inherited from the parents. This way it can be proven that one ofthe parents is a germline mosaic if an affected and an unaffected child, carrying the same chromosome from one of the parents, is en-van der Meulen, van der Meulen, te Meerman countered. Germline mosaicism is proven if at least two children have the same genotype, but different phenotype (affected and unaffected). Still, care has to be taken to exclude phenocopies, mutation in the affected child itself leading to somatic mosaicism, incomplete penetrance, or intragenic recombinations.
The formula presented in this paper has an equal conditional probability of mutation in each gonadal generation. Passos-Bueno et allo concluded that different mosaicism frequencies for proximal and distal DMD mutations exist. The proximal mutations in the DMD families are thought to have a higher recurrence risk through occurring very early in embryonal development, therefore increasing the proportion of mutated cells. The formula can be extended to take the different mutation probabilities of the different gonadal generations into account as soon as more information is available.
In practical genetic counselling, there is often no chromosomal material available from an affected diseased child. Since it is therefore unknown which chromosome of the parents is the mosaic chromosome, special care must be taken. If, for instance, there is a pedigree available with an X linked disease, one affected son genotype unknown, one unaffected son with the mother's paternal chromosome and two sons with the mother's maternal chromosome, the situation can be analysed as:
( Jeanpierre12 devised a computer program to calculate the probability of a possible carrier, in order to settle the origin of a mutation of a given family.
